APVO Insider Trading

Insider Ownership Percentage: 1.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Aptevo Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Aptevo Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aptevo Therapeutics Share Price & Price History

Current Price: $4.69
Price Change: Price Increase of +0.63 (15.52%)
As of 03/28/2024 01:00 AM ET

This chart shows the closing price history over time for APVO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aptevo Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Kevin C. TangMajor ShareholderSell5,802$309.32$1,794,674.64View SEC Filing Icon  
11/18/2021Kevin C. TangMajor ShareholderSell8,398$366.96$3,081,730.08View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Aptevo Therapeutics (NASDAQ:APVO)

8.06% of Aptevo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at APVO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aptevo Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Citadel Advisors LLC262,124$47K0.0%N/A1.391%Search for SEC Filing on Google Icon
11/15/2023Sabby Management LLC1,334,169$0.44M0.3%N/A11.581%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC1,235,000$0.41M0.0%N/A10.717%Search for SEC Filing on Google Icon
8/15/2023Cantor Fitzgerald L. P.251,122$0.37M0.0%+14.8%3.331%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC80,186$0.12M0.0%+45.8%1.063%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC54,986$0.11M0.0%-16.0%0.759%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley11,313$26K0.0%-39.9%0.222%Search for SEC Filing on Google Icon
2/9/2023Dimensional Fund Advisors LP12,705$29K0.0%N/A0.250%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can10,000$61K0.0%N/A0.196%Search for SEC Filing on Google Icon
11/15/2022Cantor Fitzgerald L. P.133,700$0.41M0.0%N/A2.627%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC16,776$51K0.0%N/A0.330%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC28,421$86K0.0%+122.6%0.558%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC12,768$46K0.0%N/A0.255%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC69,886$0.25M0.0%+18.7%1.396%Search for SEC Filing on Google Icon
8/12/2022Franklin Resources Inc.10,788$39K0.0%-32.2%0.215%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC58,886$0.35M0.0%-14.3%1.176%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp16,695$98K0.0%-26.0%0.333%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.240,819$1.41M0.0%+7.3%4.807%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp25,952$0.15M0.0%N/A0.518%Search for SEC Filing on Google Icon
12/10/2021Towercrest Capital Management211,227$3.26M0.6%N/A4.313%Search for SEC Filing on Google Icon
12/8/2021Moors & Cabot Inc.389,269$3.73M0.2%N/A7.948%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.15,650$0.24M0.0%N/A0.320%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP13,651$0.21M0.0%N/A0.279%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC143,419$2.21M0.0%-10.3%2.931%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.55,394$0.86M0.0%+1.9%1.133%Search for SEC Filing on Google Icon
11/5/2021Moors & Cabot Inc.389,269$3.73M0.3%N/A7.954%Search for SEC Filing on Google Icon
8/17/2021Balyasny Asset Management LLC18,012$0.40M0.0%-70.6%0.405%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC15,350$0.34M0.0%+4.9%0.345%Search for SEC Filing on Google Icon
8/16/2021Alyeska Investment Group L.P.139,172$3.12M0.0%-80.9%3.127%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley8,364$0.19M0.0%+163.4%0.188%Search for SEC Filing on Google Icon
8/16/2021Kennedy Capital Management Inc.187,995$4.22M0.1%N/A4.225%Search for SEC Filing on Google Icon
8/16/2021State Street Corp10,973$0.25M0.0%N/A0.247%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC159,923$3.59M0.0%-23.6%3.594%Search for SEC Filing on Google Icon
8/13/2021Anson Funds Management LP35,587$0.80M0.1%-26.6%0.800%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp22,652$0.51M0.0%+170.7%0.509%Search for SEC Filing on Google Icon
8/13/2021QS Investors LLC15,650$0.35M0.0%+37.3%0.352%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC38,917$0.87M0.0%+8.8%0.875%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.134,760$3.02M0.0%+2.9%3.028%Search for SEC Filing on Google Icon
5/17/2021Schonfeld Strategic Advisors LLC9,700$0.30M0.0%-12.6%0.218%Search for SEC Filing on Google Icon
5/14/2021RTW Investments LP281,402$8.59M0.1%-2.4%6.324%Search for SEC Filing on Google Icon
5/14/2021Dynamic Technology Lab Private Ltd14,022$0.43M0.0%+6.2%0.315%Search for SEC Filing on Google Icon
5/13/2021QS Investors LLC11,400$0.35M0.0%N/A0.256%Search for SEC Filing on Google Icon
5/13/2021JBF Capital Inc.3,907$0.12M0.0%+49.9%0.088%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC209,223$6.39M0.0%-17.8%4.702%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp9,964$0.31M0.0%N/A0.224%Search for SEC Filing on Google Icon
5/13/2021Bank of Montreal Can25,280$0.67M0.0%-20.1%0.568%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC35,762$1.09M0.0%+26.8%0.804%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.57,605$1.76M0.0%-1.0%1.294%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP5,502$0.20M0.0%N/A0.126%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP5,502$0.20M0.0%N/A0.126%Search for SEC Filing on Google Icon
2/24/2021Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133%Search for SEC Filing on Google Icon
2/18/2021Ghost Tree Capital LLC50,000$1.83M0.4%N/A1.142%Search for SEC Filing on Google Icon
2/16/2021Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133%Search for SEC Filing on Google Icon
2/16/2021Pura Vida Investments LLC8,203$0.30M0.0%N/A0.187%Search for SEC Filing on Google Icon
2/16/2021Price T Rowe Associates Inc. MD6,300$0.23M0.0%N/A0.144%Search for SEC Filing on Google Icon
2/12/2021Stonepine Capital Management LLC18,280$0.67M0.5%N/A0.417%Search for SEC Filing on Google Icon
2/11/2021JBF Capital Inc.2,607$96K0.0%N/A0.060%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp8,707$0.32M0.0%N/A0.199%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.967$35K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/11/2021Dynamic Technology Lab Private Ltd13,202$0.48M0.1%N/A0.301%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC254,423$9.33M0.0%-13.1%5.810%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN1,552$57K0.0%+241.1%0.035%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.58,168$2.13M0.0%+166.8%1.328%Search for SEC Filing on Google Icon
11/16/2020Worth Venture Partners LLC27,645$0.21M0.2%-21.8%0.667%Search for SEC Filing on Google Icon
11/9/2020Acadian Asset Management LLC45,126$0.34M0.0%-2.5%1.396%Search for SEC Filing on Google Icon
11/6/2020GSA Capital Partners LLP40,512$0.31M0.1%N/A1.253%Search for SEC Filing on Google Icon
8/5/2020WINTON GROUP Ltd11,332$95K0.0%N/A0.351%Search for SEC Filing on Google Icon
7/31/2020UBS Group AG10,015$83K0.0%-13.3%0.310%Search for SEC Filing on Google Icon
5/1/2020BlackRock Inc.21,968$81K0.0%-92.8%0.679%Search for SEC Filing on Google Icon
5/1/2020UBS Group AG11,548$43K0.0%-93.4%0.358%Search for SEC Filing on Google Icon
2/14/2020Bank of New York Mellon Corp56,181$37K0.0%-44.2%0.124%Search for SEC Filing on Google Icon
2/14/2020UBS Group AG175,092$0.12M0.0%+27.3%0.387%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC2,379,859$1.56M0.0%+9.8%5.256%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aptevo Therapeutics logo
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company's lead clinical candidates are APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelodysplastic syndromes; and. ALG.APV-527, an investigational bispecific ADAPTIR candidate that features a mechanism of action to target 4-1BB (CD137) and 5T4, a tumor antigen expressed in various types of cancers. Its preclinical candidates include APVO603, a dual agonist bispecific antibody to target 4-1BB and OX40; APVO711, a dual mechanism bispecific ADAPTIR candidate designed to provide synergistic stimulation of CD40 on antigen presenting cells; and APVO442, a bispecific candidate based on the ADAPTIR-FLEX platform technology to enhance biodistribution of drugs to PSMA positive tumors for treatment of prostate cancer. The company has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
Read More on Aptevo Therapeutics

Today's Range

Now: $4.69
Low: $3.95
High: $5.00

50 Day Range

MA: $6.08
Low: $4.01
High: $7.48

52 Week Range

Now: $4.69
Low: $3.81
High: $92.62

Volume

293,949 shs

Average Volume

102,444 shs

Market Capitalization

$2.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

4.93

Who are the major institutional investors of Aptevo Therapeutics?

Aptevo Therapeutics' top institutional shareholders include:
  1. Citadel Advisors LLC — 1.39%
  2. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Aptevo Therapeutics stock.

Which major investors are buying Aptevo Therapeutics stock?

In the last quarter, APVO stock was purchased by institutional investors including:
  1. Citadel Advisors LLC